Clinical Trial Update: Study of Novel Therapies for Young People With Recurrent/Progressive Atypical Teratoid Rhabdoid Tumor (ATRT) [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating novel therapies for pediatric atypical teratoid/rhabdoid tumor (ATRT) of the central nervous system is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atypical Teratoid Rhabdoid Tumor

Snippet

Sponsor: Sabine Mueller, MD, PhD | Conditions: Recurrent Atypical Teratoid/Rhabdoid Tumor, Atypical Teratoid/Rhabdoid Tumor (ATRT) of the CNS | Phase 2 | Status: NOT_YET_RECRUITING